The DOI matches its Crossref record; 221 of the 221 references it cites were found in a registry or an index.
Interplay between epigenetics and metabolism in oncogenesis: mechanisms and therapeutic approaches
Open accessAbstract
Epigenetic and metabolic alterations in cancer cells are highly intertwined. Oncogene-driven metabolic rewiring modifies the epigenetic landscape via modulating the activities of DNA and histone modification enzymes at the metabolite level. Conversely, epigenetic mechanisms regulate the expression of metabolic genes, thereby altering the metabolome. Epigenetic-metabolomic interplay has a critical role in tumourigenesis by coordinately sustaining cell proliferation, metastasis and pluripotency. Understanding the link between epigenetics and metabolism could unravel novel molecular targets, whose intervention may lead to improvements in cancer treatment. In this review, we summarized the recent discoveries linking epigenetics and metabolism and their underlying roles in tumorigenesis; and highlighted the promising molecular targets, with an update on the development of small molecule or biologic inhibitors against these abnormalities in cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–221 of 221
Patel, S. A., Graunke, D. M., & Pieper, R. O. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.10.5813 · Cited by 57
Ischemia dysregulates DNA methyltransferases andp16INK4amethylation in human colorectal cancer cells
Skowronski, K., Dubey, S., Rodenhiser, D. I., & Coomber, B. L. (2010) · Epigenetics · doi:10.4161/epi.5.6.12400 · Cited by 55
Thomas, M. G., Saldanha, M., Mistry, R. J., Dexter, D. T., Ramsden, D. B., & Parsons, R. B. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.200 · Cited by 55
Momparler, R. L., Idaghdour, Y., Márquez, V. E., & Momparler, L. F. (2012) · Leukemia Research · doi:10.1016/j.leukres.2012.03.001 · Cited by 54
Hattori, M., Yokoyama, Y., Hattori, T., Motegi, S., Amano, H., Hatada, I., & Ishikawa, O. (2015) · Experimental Dermatology · doi:10.1111/exd.12767 · Cited by 53
The prolyl‐hydroxylase EGLN3 and not EGLN1 is inactivated by methylation in plasma cell neoplasia
Hatzimichael, E. C., Dasoula, A., Shah, R., Syed, N., Papoudou‐Bai, A., Coley, H. M., Dranitsaris, G., Bourantas, K. L., Stebbing, J., & Crook, T. (2009) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2009.01344.x · Cited by 53
Morani, F., Phadngam, S., Follo, C., Titone, R., Aimaretti, G., Galetto, A., Alabiso, O., & Isidoro, C. (2014) · Journal of Molecular Endocrinology · doi:10.1530/jme-14-0118 · Cited by 49
Rodrigues, M. F., Carvalho, É., Pezzuto, P., Rumjanek, F. D., & Amoêdo, N. D. (2014) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25036 · Cited by 48
Targeting of cancer stem cells by inhibitors of DNA and histone methylation
Momparler, R. L., & Côté, S. (2015) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2015.1051220 · Cited by 44
Rawłuszko-Wieczorek, A. A., Bujnicka, K. E., Horbacka, K., Krokowicz, P., & Jagodziński, P. P. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-526 · Cited by 44
Place, T. L., Fitzgerald, M. P., Venkataraman, S., Vorrink, S. U., Case, A. J., Teoh-Fitzgerald, M. L. T., & Domann, F. E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0014617 · Cited by 42
Alcarraz‐Vizán, G., Boren, J., Lee, W. P., & Cascante, M. (2010) · Metabolomics · doi:10.1007/s11306-009-0192-0 · Cited by 38
Lin, S.-H., Liu, T., Ming, X., Tang, Z., Fu, L., Schmitt‐Kopplin, P., Kanawati, B., Guan, X., & Cai, Z. (2016) · Scientific Reports · doi:10.1038/srep21184 · Cited by 33
Shih, A. H., SHANK, K. R., Meydan, C., Intlekofer, A. M., Ward, P. S., Thompson, C. B., Melnick, A. M., Travins, J. M., Straley, K., Gliser, C., et al. (2014) · Blood · doi:10.1182/blood.v124.21.437.437 · Cited by 28
AG-221 Offers a Survival Advantage In a Primary Human IDH2 Mutant AML Xenograft Model
Yen, K. E., Wang, F., Travins, J. M., Chen, Y., Yang, H. Q., Straley, K., Choe, S. E., Dorsch, M., Schenkein, D. P., Agresta, S. V., et al. (2013) · Blood · doi:10.1182/blood.v122.21.240.240 · Cited by 26
Zhou, F., Huo, J., Liu, Y., Liu, H., Liu, G., Chen, Y., & Chen, B. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.02.015 · Cited by 26
Regulation of Human RNA Polymerase III Transcription by DNMT1 and DNMT3a DNA Methyltransferases
Selvakumar, T., Gjidoda, A., Hovde, S., & Henry, R. W. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.285601 · Cited by 25
Rodríguez‐Paredes, M., & Esteller, M. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0271 · Cited by 23
Muñoz‐Pinedo, C., González‐Suárez, E., Portela, A., Gentilella, A., & Esteller, M. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0512 · Cited by 7
Identification of a New Selective Chemical Inhibitor of Mutant Isocitrate Dehydrogenase-1
Kim, H.-J., Choi, B. Y., & Keum, Y. (2015) · Journal of Cancer Prevention · doi:10.15430/jcp.2015.20.1.78 · Cited by 7
Abstract 3116: AG-221 offers a survival advantage in a primary human IDH2 mutant AML xenograft model
Ellwood-Yen, K., Wang, F., Travins, J. M., Chen, Y., Yang, H. Q., Straley, K., Choe, S. E., Dorsch, M., Agresta, S., Schenkein, D. P., et al. (2014) · Cancer Research · doi:10.1158/1538-7445.am2014-3116 · Cited by 6
Cited by
Metabolic reprogramming and epigenetic modifications on the path to cancer
Sun, L., Zhang, H., & Gao, P. (2022) · Protein & Cell · doi:10.1007/s13238-021-00846-7 · Cited by 770
Hypoxia-Modified Cancer Cell Metabolism
Al Tameemi, W., Dale, T. P., Al-Jumaily, R. M. K., & Forsyth, N. R. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00004 · Cited by 503
Fibroblast-like synoviocyte metabolism in the pathogenesis of rheumatoid arthritis
Bustamante, M. F., Garcia-Carbonell, R., Whisenant, K. D., & Guma, M. (2017) · Arthritis Research & Therapy · doi:10.1186/s13075-017-1303-3 · Cited by 407
Age-induced accumulation of methylmalonic acid promotes tumour progression
Gomes, A. P., Ilter, D., Low, V., Endress, J. E., Fernández-García, J., Rosenzweig, A., Schild, T., Broekaert, D., Ahmed, A., Planque, M., et al. (2020) · Nature · doi:10.1038/s41586-020-2630-0 · Cited by 244
Autophagy Regulation of Metabolism Is Required for CD8+ T Cell Anti-tumor Immunity
DeVorkin, L., Pavey, N., Carleton, G., Comber, A., Ho, C., Lim, J., McNamara, E., Huang, H., Kim, P., Zacharias, L. G., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.03.037 · Cited by 185
Metadata
- Authors
- Wong, C. C., Qian, Y., & Yu, J.
- Venue
- Oncogene
- Published
- 2017-01-16
- Volume
- 36
- Issue
- 24
- Pages
- 3359-3374
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2579290699
- Cited by
- 262
- References
- 221
- FWCI
- 10.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.